Pictures and news reports from the Pars Isotope booth at the conference of South African Society of Nuclear Medicine (SASNM)
The new phantom manufactured by Pars Isotope Co. received approval from Imam Khomeini Hospital in Tehran.
Obtaining a bilingual GMP certificate from Iran Food and Drug Administration (IFDA) for the production lines of FDG radiopharmaceutical and the Pars-GalluGEN generator
The presence of Pars Isotope Co. in International Symposium on Trends in Radiopharmaceuticals in Austria
The Administrator of Drug and Controlled Substances Affairs of the Food and Drug Organization Visited Pars Isotope Company.
Utilizing radiopharmaceuticals made by Pars Isotope Co. for the feasibility and investigation of the therapeutic potential of (Ga-68/Lu-177)-DOTATATE theranostic pair in patients with metastatic medullary thyroid carcinoma.